FAKTU

국가: 인도네시아

언어: 인도네시아어

출처: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Download 제품 특성 요약 (SPC)
14-12-2021

유효 성분:

POLICRESULEN, CINCHOCAINE HYDROCHLORIDE

제공처:

PHAROS INDONESIA - Indonesia

INN (국제 이름):

POLICRESULEN, CINCHOCAINE HYDROCHLORIDE

복용량:

50 MG /10 MG

약제 형태:

SALEP

패키지 단위:

DUS, 1 TUBE @ 20 G

Manufactured by:

PRIMA MEDIKA LABORATORIES - Indonesia

승인 날짜:

2021-12-14

제품 특성 요약

                                FAKTU
SALEP
COMPOSITION
®
.
FAKTU OINTMENT
1 g contains 50 mg of policresulen and 10 mg of cinchocaine
hydrochloride.
ACTION AND USES
®
FAKTU for use in the treatment of haemmorrhoidal conditions is
available as ointment.
Presentation
forms
contain
policresulen
and
the
local
anesthetic
cinchocaine as active substances. The astringent, bactericidal and
®
haemostatic actions of FAKTU have proved useful in the therapy of
®
anorectal
diseases.
The
essential
active
principle
of
FAKTU
:
policresulen exerts a selective action upon necrotic tissue without
affecting healthy epithelium. Pathologically changed tissue is
coagulated
to be subsequently cast off. Bleedings are promptly controlled, since
a
protective film is formed upon wound areas, consisting of denatured
protein and anal capillaries are constricted and closed.
Oozing and itching are removed. Regeneration is further promoted by
the
hyperemic effect induced by the preparations. The bactericidal effect
of
®
FAKTU prevents or controls inflammatory processes. Cinchocaine has
shown to be useful in proctology, providing relief of pain and
itching.
®
FAKTU
quickly
eliminates
bleeding,
oozing,
and
itching
in
haemmorrhoidal
diseases
and
other
anorectal
disorders,
prevents
inflammation and stimulates the regeneration of the affected tissue.
INDICATIONS
.
Haemmorrhoids
®
FAKTU ointment for internal and external use, especially those
associated with inflammatory conditions or bleeding.
.
Anal fissures
DOSAGE AND ADMINISTRATION
OINTMENT :
The ointment is applied 2 - 3 times daily to the affected area. Rectal
insertion of ointment requires prior evacuation of bowel; use enclosed
applicator for introduction.
CONTRAINDICATION
®
FAKTU must not be used in case of hypersensitivity to cinchocaine or
to
®
any of the excipients. FAKTU contain phopholipids from soya beans. In
case of hypersensivity to soya or peanuts.
UNDESIRABLE EFFECTS
The following frequency convention is used in the evaluation of side
effects:
Very common : more than 1 in 10 patients treated.
Uncommon : 
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림

문서 기록보기